Aryavan Enterprise Ltd Q3 Results
- BSE: 539455
- NSE: -
- ISIN: INE360S01012
- Sector: Biotechnology & Drugs
BSE
52.25
1.53 (3.02%)
1.53 (3.02%)Volume18.12 K
Updated: Fri 6 Feb, 2026 | 15:24:54
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Aryavan Enterprise Ltd Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 8.66 | 6.11 | 41.68% |
| Depreciation/ Amortization | 0.01 | - | N/A |
| Operating Income | 0.29 | 0.29 | 0.49% |
| Net Income | 0.25 | 0.25 | 1.16% |
| Other Operating Expenses Total | 0.03 | 0.02 | 105.13% |
| Net Income Before Taxes | 0.36 | 0.33 | 10.75% |
| Total Revenue | 8.94 | 6.40 | 39.83% |
| Selling/ General/ Admin Expenses Total | 0.09 | 0.03 | 224.03% |
| Diluted Normalized EPS | 0.54 | 0.65 | -16.92% |